Ganciclovir [clinicaltrials_resource:faf30abfb2b4016270fc4af04ccddf26]
clinicaltrials:NCT00000134Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) [clinicaltrials:NCT00000136]Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) [clinicaltrials:NCT00000143]Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component [clinicaltrials:NCT00000665]A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir [clinicaltrials:NCT00000668]A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy [clinicaltrials:NCT00000673]A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS [clinicaltrials:NCT00000688]A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure [clinicaltrials:NCT00000691]A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir [clinicaltrials:NCT00000697]A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis [clinicaltrials:NCT00000698]CMV Retinitis Retreatment Trial [clinicaltrials:NCT00000766]A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients [clinicaltrials:NCT00000768]A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease [clinicaltrials:NCT00000805]A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease. [clinicaltrials:NCT00000856]Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis [clinicaltrials:NCT00000894]A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir [clinicaltrials:NCT00000970]The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS [clinicaltrials:NCT00000989]A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection [clinicaltrials:NCT00000995]The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV [clinicaltrials:NCT00001034]Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS [clinicaltrials:NCT00001061]A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes [clinicaltrials:NCT00001062]A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections. [clinicaltrials:NCT00001100]Gene Therapy for the Treatment of Brain Tumors [clinicaltrials:NCT00001328]A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS [clinicaltrials:NCT00001999]An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children [clinicaltrials:NCT00002015]Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections [clinicaltrials:NCT00002024]Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient [clinicaltrials:NCT00002025]A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS [clinicaltrials:NCT00002034]Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis [clinicaltrials:NCT00002070]A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus [clinicaltrials:NCT00002095]A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine [clinicaltrials:NCT00002096]A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis [clinicaltrials:NCT00002134]An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access [clinicaltrials:NCT00002135]A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) [clinicaltrials:NCT00002156]A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS [clinicaltrials:NCT00002222]A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy [clinicaltrials:NCT00002247]A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir [clinicaltrials:NCT00002251]A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS [clinicaltrials:NCT00002257]A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS [clinicaltrials:NCT00002273]The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS [clinicaltrials:NCT00002299]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Ganciclovir [clinicaltrials_resource:faf30abfb2b4016270fc4af04ccddf26]
Bio2RDF identifier
faf30abfb2b4016270fc4af04ccddf26
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:faf30abfb2b4016270fc4af04ccddf26
identifier
clinicaltrials_resource:faf30abfb2b4016270fc4af04ccddf26
title
Ganciclovir
@en
type
label
Ganciclovir [clinicaltrials_resource:faf30abfb2b4016270fc4af04ccddf26]
@en